SeekIn 思勤


    seek and you will find


  • About us

    Despite the significant increase of our knowledge about carcinogenesis and recent successful development of innovative cancer drugs, including targeted therapies and immunotherapies, cancer mortality has only slightly decreased in the past decades. Cancer early detection is probably the most cost-effective means to reduce cancer mortality as prognosis is much better when cancer is detected and treated at the early stage.

    SeekIn is a startup focusing on blood-based cancer early diagnosis with a mission to reduce cancer mortality by 10% in the screened population by 2030. Our proprietary ctDNA mutation detection technology has demonstrated its promise to identify asymptomatic cancer patients from general population.

  • With technology getting more advanced, we can now choose our life and our death. It's now possible to eliminate certain congenital diseases that would otherwise be present upon birth. It's the same with death - we want to die in our sleep rather than experiencing a painful death that torments us.
    We will decipher the cancer code, and achieve our goal of detecting cancer early. There will be cancer, but we will not die from cancer.




    —— Mao Mao

    MAOMAO's TEDxTheBund talk

  • Our solution

    multiplex, stepwise, cost-effective blood-based cancer screening

    A NGS test to capture cancer genetic features in plasma.

    To calculate cancer risk score.

    Non-invasive blood based screening method,10ml blood.


    ©2018 SeekIn Cancer. All Rights Reserved. 粤ICP备18059743号-1 粤公网安备 44030802000447号